Latest Form 4 insider transactions

Manuela Valente, Chief People Officer of SOPHiA GENETICS SA, sold 4,240 shares of common stock on October 5, 2026 for $8.13 per share.

Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS SA, sold 5,284 shares of common stock on October 5, 2026 for $8.12 per share.

Kevin Puylaert, Chief Sales Officer of SOPHiA GENETICS SA, sold 216 shares of common stock on October 5, 2026.

George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA, sold 1,592 shares of common stock on October 5, 2026 for $8.10 per share.

Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 7,394 shares of common stock on October 5, 2026 for $8.13 per share.

Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 40,172 shares of common stock on October 5, 2026 for $8.13 per share.

Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS SA, sold 7,394 shares of common stock on October 5, 2026 for $8.12 per share.

Ross Muken, Chief Executive Officer and a Director of SOPHiA GENETICS SA, sold 9,838 shares of common stock on October 5, 2026 for $8.13 per share.

Andrew Luen Cheung Wong, a Director of Canadian Solar Inc., reported multiple transactions in common stock on October 6, 2026.

Bryan F. Cox, Chief of Research of TriSalus Life Sciences, Inc., sold 296 shares of common stock on October 5, 2026 for $4.39 per share.

Richard Marshak, Chief Commercial Officer of TriSalus Life Sciences, Inc., sold 325 shares of common stock on October 5, 2026 for $4.39 per share.

Jennifer Stevens, Chief Regulatory Officer of TriSalus Life Sciences, Inc., sold 316 shares of common stock on October 5, 2026 for $4.39 per share.

Mary T Szela, CEO and President and a Director of TriSalus Life Sciences, Inc., reported a transaction in 2,693 shares of common stock on October 5, 2026.

Fred Aslan, Chief Executive Officer and a Director of Artiva Biotherapeutics, Inc., sold 23,463 shares of common stock on October 6, 2026 for $7.20 per share.

Yuan Qu, a Director of Canadian Solar Inc., reported multiple transactions in common stock on October 6, 2026.

Leon Richardson, a Director of Global Net Lease, Inc., received 3,481 shares of common stock on October 6, 2026.

Mahesh Choudhury, Principal Financial Officer of ConnectM Technology Solutions, Inc., purchased 683 shares of common stock on September 2, 2026.

Robert I Kauffman, a Director of Global Net Lease, Inc., received 4,389 shares of common stock on October 6, 2026.

Robert Taglich, a 10% owner of Intellinetics, Inc., purchased 4,000 shares of common stock on October 6, 2026 for $5.00 per share.

Hyong Kim, Chief Medical Officer of Alignment Healthcare, Inc., sold 32,479 shares of common stock on October 6, 2026 for $8.30 per share.

George M Milne Jr, a Director of Amylyx Pharmaceuticals, Inc., sold 30,000 shares of common stock on October 5, 2026 for $27.70 per share.

Donald W Degolyer, a Director of Emergent BioSolutions Inc., sold 17,800 shares of common stock on October 7, 2026 for $7.09 per share.

Thomas Gregor Ilg, Chief Risk Officer of StoneCo Ltd., received 18,339 shares of common stock on October 6, 2026.

Derrick L Johnson, a Director of LXP Industrial Trust, received 542 shares of common stock on October 7, 2026.

Jamie Handwerker, a Director of LXP Industrial Trust, received 542 shares of common stock on October 7, 2026.

Arun Gupta, a Director of LXP Industrial Trust, received 542 shares of common stock on October 7, 2026.

Lawrence L Gray, a Director of LXP Industrial Trust, received 542 shares of common stock on October 7, 2026.

Claire A Koeneman, a Director of LXP Industrial Trust, received 542 shares of common stock on October 7, 2026.

Nancy Elizabeth Noe, a Director of LXP Industrial Trust, received 542 shares of common stock on October 7, 2026.

Howard Stewart Roth, a Director of LXP Industrial Trust, received 542 shares of common stock on October 7, 2026.